Purchase Order 75N98025P00596

<p>This is a $20,000.00 firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturer, on August 6, 2024. The contract has an ultimate completion date of August 5, 2025 and does not utilize a set-aside. The place of performance is India. No additional details about the specific products or services being acquired are provided.</p>

This is a firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian federal agency, to Editco Bio Inc., a self-certified small disadvantaged business. The contract, valued at $24,150.00, is for the delivery of 2 SFRP1-HIBIT-TAGGED CELL LINES FOR SMALL MOLECULE SCREENING. The contract has an ultimate completion date of April 30, 2025 and was awarded on December 11, 2024. This contract is not associated with a larger vehicle and does...

<p>This is a $92,334.95 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Apexbio Technology, LLC, a small business, for the delivery of 2,234 compounds of 5mg size. The contract has a completion date of July 20, 2015. This contract award is not associated with a larger contract vehicle.</p>

This is a federal contract award to Aapharmasyn LLC, a small disadvantaged business, for Experimental Therapeutics Medicinal Chemistry services. The contract was awarded by the Defense Health Agency, a component of the U.S. Department of Defense, with a ceiling value of $77,780.00. The contract has a firm fixed price pricing type and was awarded as a delivery order under the Experimental Therapeutics Medicinal Chemistry contract vehicle. The contract does not have a set-aside designation. The...

This is a firm fixed price purchase order contract awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to 10X Genomics, Inc., a for-profit manufacturer, on July 29, 2024. The contract has a ceiling value of $17,810.00 and a period of performance through July 28, 2025. 10X Genomics, a life sciences technology company, is providing products and services related to single-cell and spatial analysis applications to support biomedical research, primarily for the...

<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>

This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...

This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Chiralix B.V., a for-profit organization, for the custom synthesis of a cyclic depsipeptide titled &quot;CLOSELY ASSOCIATED&quot;. The award has a ceiling value of $19,160.00 and an ultimate completion date of July 31, 2015. The contract was awarded on March 4, 2015 and does not have a set-aside designation.</p>

<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>